Bank of New York Mellon’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,413
| Closed | -$66K | – | 4739 |
|
|
2022
Q1 | $66K | Sell |
3,413
-557
| -14% | -$10.8K | ﹤0.01% | 4481 |
|
|
2021
Q4 | $142K | Buy |
3,970
+927
| +30% | +$33.2K | ﹤0.01% | 4348 |
|
|
2021
Q3 | $223K | Buy |
3,043
+962
| +46% | +$70.5K | ﹤0.01% | 4161 |
|
|
2021
Q2 | $290K | Buy |
2,081
+752
| +57% | +$105K | ﹤0.01% | 3974 |
|
|
2021
Q1 | $386K | Buy |
+1,329
| New | +$386K | ﹤0.01% | 3818 |
|